News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
140 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (4372)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Genetown
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
These awards were granted pursuant to the Paratek Pharmaceuticals, Inc. 2017 Inducement Plan.
December 4, 2017
·
4 min read
NW Bio Announces Completion of $12M Financing
The financing is in the form of Series A Convertible Preferred Stock and Warrants.
December 4, 2017
·
4 min read
Business
Metrics Contract Services Appoints Associate Director of Pharmaceutical Development
Sadhale will manage all aspects of formulation development and manufacturing of a client’s clinical trial materials.
December 4, 2017
·
2 min read
Business
Phosphagenics Signs a Multinational License for TPM in Personal Care Products
Under the terms of the agreement, R+F will be responsible for all development and commercialisation of TPM-based personal care products.
December 4, 2017
·
3 min read
Biotech Beach
Tioga Pharma’s Asimadoline Reduces Nighttime Itching and Improves Disease-Related Quality of Life in Patients with Atopic Dermatitis
This proof-of-concept study was performed at 25 sites across the U.S.
December 4, 2017
·
3 min read
Business
22nd Century Hires Former BAT Head of Plant Biotechnology
At 22nd Century, Dr. Tamburrino will assume the role of Vice President of Research and Development upon the retirement, at the end of this month, of Dr. Michael Moynihan.
December 4, 2017
·
5 min read
Biotech Beach
Heron Therapeutics Announces Public Offering of Common Stock on Dec. 1
Heron Therapeutics today announced an underwritten public offering of its common stock. The closing price of Heron Therapeutics, Inc.’s common stock on December 1, 2017 was $17.25 per share.
December 4, 2017
·
2 min read
Valeant Pharmaceuticals Announces Pricing of Private Offering of Senior Notes
The Notes will be guaranteed by each of the Company’s subsidiaries that are guarantors under the Company’s credit agreement and the Company’s existing senior notes.
December 4, 2017
·
4 min read
NanoSphere Health Sciences Announces Name Change, CSE Listing and Conversion of %5.9M in Subscription Receipts
NanoSphere’s shares will commence trading tomorrow, December 5, 2017, under the symbol “NSHS”.
December 4, 2017
·
5 min read
Business
Olainfarm Will Hold Third Quarter 2017 Investor Conference Webinar
Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.
December 4, 2017
·
1 min read
Previous
12 of 14
Next